Contact Us
Drug Search Results
More Filters [+]

Fosamprenavir

Alternative Names: fosamprenavir, gw-433908, gw433908, gw 433908, lexiva
Latest Update: 2024-11-25
Latest Update Note: Clinical Trial Update

Product Description

Fosamprenavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Fosamprenavir is in a class of medications called protease inhibitors. It works by decreasing the amount of HIV in the blood. (Sourced from: https://medlineplus.gov/druginfo/meds/a604012.html)

Mechanisms of Action: HIV Protease Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hungary | Iceland | Ireland | Italy | Japan | Latvia | Lithuania | Luxembourg | Netherlands | Norway | Poland | Portugal | Romania | Russia | Slovakia | South Africa | Spain | Sweden | Switzerland | Turkey | United Kingdom | United States | Uruguay | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fosamprenavir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

01/29/2024

News Article

 Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections

04/10/2023

News Article

 Antimicrobial Therapeutics Market size to grow by USD 51.4 billion from 2022 to 2027, Driven by initiatives from government agencies in the pharmaceutical industry - Technavio

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions